Tree.com (TREE) came out with quarterly earnings of $0.99 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.70 per share a year ago.
TREE and NRDS are expanding their market share in the digital marketplace. Read on to know which is a smart bet for now.
TREE is set to report first-quarter 2025 results next week. Read on to know whether you should buy the stock now or wait.
TREE's revenue diversification efforts and expense management initiatives look encouraging. Read on to see whether the stock deserves a spot in your portfolio.
Tree.com (TREE) reported earnings 30 days ago. What's next for the stock?
Tree.com (TREE) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Tree.com (TREE) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
The consensus price target hints at a 28.4% upside potential for Tree.com (TREE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Another one of those stocks that is seeing a big turnaround in earnings after a mighty slump a couple of years ago.
Tree.com (TREE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Tree.com (TREE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.